COURSE CREDITS & HOURS
18 AMA PRA Category 1 Credits™18 ACPE Credits
18 ANCC Contact Hours
COURSE FEES
$1,195.00 for Physicians
$895.00 for Nurse Practitioners, Physician Assistants, Pharmacists
$695.00 for Nurses, Pharmacy Technicians
TARGET AUDIENCE
Physicians, Nurse Practitioners, Physician Assistants, Pharmacists, Nurses, Pharmacy Technicians
PROGRAM TOPICS
Dr. Wolf's Topics
- Hematuria Evaluation and Urologic Cancers
- Describe motivations behind hematuria evaluation, and outline its best practice
- Summarize important features, including screening strategies, of 4 most common urologic cancers
- Urinary Calculi
- Describe the epidemiology, impact and pathophysiology of urinary calculi
- Differentiate indications for referral versus primary management of patients with urinary calculi, and identify appropriate treatment modalities
- Evaluate strategies for secondary prevention of urinary calculi
- Urinary Tract Infections
- Explain how to distinguish asymptomatic bacteriuria (ASB) from a urinary tract infection (UTI), and identify who should and should not be tested and treated for ASB
- Recommend appropriate evaluation and empiric treatments for UTIs
- Determine when referral to a specialist should be made, and propose strategies for management of recurrent UTIs
- Male Sexual Health and Penoscrotal Pathology
- Explain the management of penile issues including erectile dysfunction, premature ejaculation, Peyronie's disease, and priapism
- Formulate a guideline-based assessment and treatment of male hypogonadism
- Describe the male factor contributions to infertility
- Summarize an overview of common penoscrotal pathology
- Lower Urinary Tract: Obstruction and incontinence
- Outline the differential diagnosis and evaluation of lower urinary tract obstruction in men and women, and compare management options
- Provide a step-wise approach to the management of lower urinary tract symptoms in men and women
- Explain the treatment strategies for urinary incontinence in women
- Upper Urinary Tract
- Differentiate between obstructive and non-obstructive hydronephrosis
- Propose strategies for managing upper urinary tract obstruction
- Evaluate renal masses and cysts, and outline their general management
- Chronic Pelvic Pain Syndrome & Chronic Scrotal Contents Pain in Men
- Describe the demographics and etiology of chronic pelvic pain syndromes and chronic scrotal contents pain in men
- Outline the evaluation and assessment of chronic pelvic pain syndromes and chronic scrotal contents pain in men
- Determine primary-care management of chronic pelvic pain syndromes and chronic scrotal contents pain in men
- Artificial Intelligence in Healthcare
- Define the basics of AI, ML, and LLMs
- Identify current applications of AI in healthcare
- Analyze future applications and ethical concerns
- Genitourinary Syndrome of Menopause
- Explain the pathophysiology of GSM and formulate a diagnostic approach based on a focused history and physical examination.
- Summarize the evidence-based hormonal and non-hormonal treatment options for GSM.
- Develop counseling strategies for patients with GSM, including addressing common safety concerns and managing special populations.
Dr. Rodgers' Topics
- Cardiometabolic Syndrome and GLP-1 Agonists
- Explain the mechanisms by which obesity—particularly visceral adiposity—drives cardiometabolic risk, including insulin resistance, inflammation, dyslipidemia, and cardiovascular remodeling.
- Interpret clinical trial and meta-analysis data to assess the impact of GLP-1 receptor agonists and dual GIP/GLP-1 agonists on cardiovascular, renal, and metabolic outcomes in patients with and without diabetes.
- Apply evidence-based guidelines to select appropriate patients for GLP-1–based therapies, incorporating efficacy, safety, contraindications, and cardiometabolic risk reduction.
- Diet and Heart Disease
- Assess cardiovascular risk using clinical data (family history, lipid profile, metabolic syndrome criteria, and coronary artery calcium scoring) to guide prevention strategies in asymptomatic adults.
- Compare and interpret the evidence supporting major dietary patterns (Mediterranean, DASH, Ornish/plant-based) in reducing cardiovascular events, blood pressure, and progression to diabetes.
- Apply practical, evidence-based nutritional recommendations—including fat quality, glycemic load, fiber, and sodium intake—to reduce cardiometabolic risk, particularly in patients who are statin-intolerant or have metabolic syndrome.
- Hypertension Update
- Diagnose and classify hypertension by accurately interpreting blood pressure measurements, staging severity, and identifying hypertensive urgency or emergency.
- Evaluate evidence from major trials and guidelines (including SPRINT and ACC/AHA recommendations) to determine individualized blood pressure targets, weighing cardiovascular benefit against potential harms.
- Apply a stepwise, patient-centered treatment strategy for hypertension—including lifestyle modification, pharmacologic therapy, and evaluation for secondary causes—across diverse clinical scenarios.
- Chest Pain Evaluation
- Differentiate life-threatening and non-life-threatening causes of chest pain by integrating history, ECG findings, cardiac biomarkers, and bedside imaging in the acute care setting.
- Interpret troponin patterns, ECG changes, and imaging results to classify myocardial infarction subtypes (including STEMI, NSTEMI, MINOCA, and INOCA) and guide further diagnostic testing.
- Apply a risk-based chest pain algorithm to select appropriate diagnostic strategies (stress testing, coronary CT angiography, invasive angiography, or coronary calcium scoring) for low-, intermediate-, and high-risk patients.
- Pre-operative Evaluation
- Assess perioperative cardiovascular risk by integrating patient-specific factors, functional capacity, and procedure-related risk using established risk indices and ACC/AHA guidelines.
- Interpret perioperative troponin elevations, ECG findings, and clinical context to identify perioperative myocardial infarction and distinguish ischemic injury from nonischemic causes.
- Apply evidence-based decision-making to preoperative testing, revascularization, and perioperative medication management (beta blockers, statins, antiplatelet therapy) to minimize cardiac and bleeding risk in noncardiac surgery.
- Erectile Dysfunction: A Cardiologist's Perspective
- Describe the epidemiology, risk factors, and underlying physiology of erectile dysfunction, with emphasis on endothelial dysfunction and its relationship to cardiovascular disease.
- Evaluate men with erectile dysfunction by interpreting validated assessment tools (IIEF-5), clinical history, laboratory testing, and medication effects to distinguish physiologic from psychogenic causes.
- Apply evidence-based treatment strategies for erectile dysfunction, including lifestyle modification, PDE-5 inhibitor selection and safety considerations, and referral for second-line or advanced therapies when indicated.
- Statin Intolerance
- Differentiate true statin intolerance from perceived or secondary causes of muscle symptoms by interpreting clinical patterns, laboratory findings, and the Statin Myalgia Index.
- Evaluate cardiovascular risk and LDL-cholesterol goals to determine appropriate lipid-lowering strategies, including statin rechallenge, dose modification, and combination therapy.
- Apply evidence-based nonstatin therapies (ezetimibe, bempedoic acid, PCSK9 inhibitors, and dietary interventions) to achieve LDL reduction and reduce cardiovascular risk in patients with statin intolerance.
- Heart Failure Part I
- Describe heart failure as a progressive clinical syndrome by identifying its epidemiology, stages, and characteristic signs and symptoms.
- Explain the underlying pathophysiology of heart failure, including neurohormonal activation and cardiac remodeling, and differentiate HFrEF from HFpEF.
- Evaluate patients with suspected or established heart failure to identify etiology and disease stage, using appropriate imaging and diagnostic strategies to guide management.
- Heart Failure Part II
- Compare evidence-based pharmacologic and device therapies for HFrEF by distinguishing treatments that improve survival from those that primarily improve quality of life or confer harm.
- Apply guideline-directed medical therapy (GDMT) for heart failure by selecting and sequencing ACE inhibitors/ARBs/ARNIs, beta-blockers, MRAs, SGLT-2 inhibitors, and device therapies based on disease stage and patient characteristics.
- Evaluate patients with HFpEF or special etiologies (e.g., amyloidosis, hypertrophic cardiomyopathy, obesity-related HF) to individualize management strategies that optimize symptoms and clinical outcomes.
COURSE OVERVIEW BY PROFESSION
This conference provides physicians with advanced, evidence-based updates in cardiology and urology to refine diagnostic acumen and optimize therapeutic strategies. The curriculum delves into complex clinical challenges, including differentiating myocardial infarction subtypes, applying guideline-directed medical therapy for heart failure, and managing urologic cancers and chronic pelvic pain. You will explore the latest data on cardiometabolic health, including GLP-1 agonists, and gain practical insights into the emerging role of generative AI in clinical practice, enhancing your ability to lead the care team and improve patient outcomes.
Enhance your practice by learning to apply recent trial data to hypertension management, develop strategies for statin-intolerant patients, and implement guideline-based evaluation of hematuria and male hypogonadism. This 12-night cruise conference offers up to 18.00 AMA PRA Category 1 Credits™. The unique format facilitates in-depth learning and peer exchange in a setting free from daily clinical pressures, ensuring you return with actionable knowledge to immediately apply to your patient care.
This program is designed to enhance the nurse practitioner's role in managing common and complex conditions across the lifespan. The dual focus on cardiology and urology provides practical strategies for chronic disease management, health promotion, and patient counseling. You will gain confidence in addressing high-prevalence issues such as hypertension, cardiometabolic syndrome, recurrent UTIs, and men's and women's sexual health, including GSM. The content directly supports the NP’s scope of practice, empowering you to provide comprehensive, evidence-based care and improve long-term patient outcomes.
You will learn to apply nutritional recommendations for cardiovascular risk reduction, select appropriate GLP-1 therapies, manage lower urinary tract symptoms, and counsel patients on erectile dysfunction. This conference provides up to 18.00 contact hours of continuing education, acceptable for ANCC and AANP certification renewal. The cruise setting offers a unique opportunity for focused learning and networking with colleagues and expert faculty, away from clinical demands, to strengthen your practice.
This conference strengthens the physician assistant's capacity to diagnose, treat, and manage patients across a spectrum of care settings. With in-depth sessions on cardiology and urology, the program equips you with updated clinical knowledge for everything from primary care consultations to preoperative evaluations. You will refine your skills in assessing common but critical presentations like chest pain, hematuria, and lower urinary tract symptoms. This course is designed to expand your clinical confidence and enhance your collaborative role within the healthcare team, directly contributing to more efficient and effective patient care.
Specific learning objectives include applying risk-based algorithms for chest pain, conducting evidence-based preoperative cardiac assessments, and managing urinary calculi and recurrent UTIs. You will also explore male sexual health and the applications of AI in medicine. This program offers up to 18.00 AAPA Category 1 CME credits. The immersive learning environment of a 12-night cruise allows for concentrated study and valuable interaction with faculty, ensuring you integrate new protocols and knowledge into your practice.
This program provides nurses with essential clinical updates in cardiology and urology to enhance patient assessment, education, and advocacy. The curriculum focuses on practical knowledge that can be immediately applied at the bedside and in outpatient settings. You will deepen your understanding of the pathophysiology and management of heart failure, hypertension, and cardiometabolic syndrome. Sessions on urologic conditions like UTIs, urinary calculi, and pelvic pain will strengthen your ability to monitor patients, anticipate needs, and provide effective, evidence-based nursing care as a vital member of the healthcare team.
You will learn to better educate patients on lifestyle modifications for heart disease, recognize key considerations for new therapies like GLP-1 agonists, and understand management strategies for recurrent UTIs and genitourinary syndrome of menopause. This conference offers up to 18.00 ANCC Contact Hours. The unique educational format aboard this 12-night cruise provides a distraction-free environment to absorb critical information, ensuring you return to your practice with increased confidence and competence in caring for patients with complex health needs.
IMPORTANT INFORMATION
PLEASE NOTE: To attend the conference, participants must book their cruise accommodations through Continuing Education, Inc. This ensures we can provide full conference services and complimentary social amenities to meeting participants and guests. Participants' family and friends are welcome to book within our group allotment to take advantage of our typically excellent rates. Thanks for your cooperation. We look forward to welcoming you aboard!
BIAS FREE CME - No Commercial Support was provided for this CME activity.
